Who Owns AngioDynamics Company?

Who Owns AngioDynamics?

AngioDynamics is a public company, so ownership is spread across shareholders, not a single parent or family. Its control comes from voting stock, the board, and large investors.

That means the real answer is less about one owner and more about who can shape strategy. For a quick view of its market context, see AngioDynamics Balanced Scorecard.

AngioDynamics ownership today is public and widely held, not tied to a founder, family, parent, or private sponsor. In practical terms, AngioDynamics shareholders include institutions, index funds, mutual funds, and retail holders, while insiders hold only a smaller stake.

Public ownership model

AngioDynamics is publicly traded, so ownership is spread across many AngioDynamics stockholders. No single owner controls the full equity base.

Early ownership shifted

The early ownership base was private before the public listing. After that, control moved into the market through AngioDynamics investors.

Board matters most

In a public-company ownership structure, the board is key. Shareholders elect directors, and directors oversee management.

Institutional holders lead

AngioDynamics institutional ownership is central to governance pressure. Large holders can influence discipline, capital use, and oversight.

Insider stake is limited

AngioDynamics insider ownership is smaller than control owners usually hold. That means no officer or director can act like a controlling shareholder.

More transparency

Public reporting improves visibility for investors. Quarterly filings, proxy data, and SEC disclosure make the AngioDynamics company profile easier to check.

For readers asking who owns AngioDynamics, the short answer is that AngioDynamics shareholders do. The company is not privately owned, so AngioDynamics stock ownership breakdown is shaped by the market, not by one founder or sponsor. See the related Mission, Vision & Core Values of AngioDynamics piece for more context on the business profile.

What ownership means here

AngioDynamics public company ownership structure gives investors visibility, but it also spreads control. That makes governance depend on votes, filings, and board oversight.

• No controlling founder or family
• No private-equity sponsor or parent
• Institutional holders drive oversight
• Proxy voting shapes board control

AngioDynamics SWOT Analysis

• Organized to Save Time on Analysis
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

AngioDynamics was founded in 1988 and became publicly traded in 2004, so its ownership has shifted from founder-led buildout to public-market discipline. Today, Who owns AngioDynamics is shaped mainly by open-market holders, institutions, employee equity, and a smaller insider stake rather than any family or trust block.

This AngioDynamics company profile points to a classic public company ownership structure: no founder-controlled trust, no family block, and no private owner. That makes AngioDynamics public company ownership structure more dependent on earnings delivery, board oversight, and Brief History of AngioDynamics than on legacy control.

AngioDynamics ownership and market trust

Public ownership can help AngioDynamics in clinical markets because buyers often care more about proof than family control. It also puts more weight on execution, cash use, and product quality.

• Institutional holders shape trading and voting.
• Insider ownership supports alignment, not control.
• Public float broadens investor scrutiny.
• Weak results raise governance pressure fast.

The AngioDynamics stock ownership breakdown matters because it affects how the market reads trust. When a company is not privately owned, public confidence comes from governance, clinical evidence, and repeatable performance, not from a founder story. For that reason, AngioDynamics shareholders and AngioDynamics stockholders tend to focus on execution quality, margin trend, and balance sheet discipline.

In practice, AngioDynamics institutional ownership usually matters more than any single retail holder, while AngioDynamics insider ownership helps show whether management has skin in the game. The key question for investors is not whether AngioDynamics is privately owned, because it is not, but whether its AngioDynamics largest investors and AngioDynamics major institutional holders are supportive of long-term operating progress.

The result is a more neutral brand meaning with physicians and hospital buyers, but also a more demanding capital market. If performance weakens, AngioDynamics executive ownership and AngioDynamics board of directors ownership will get more attention from analysts, since public-company owners can press hard on costs, strategy, and returns.

AngioDynamics Ansoff Matrix

• Structured to Support Better Decisions
• Effortlessly Communicate Your Business Strategy
• Investor-Ready Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

AngioDynamics board of directors is led by a mix of independent directors and senior management, with the CEO handling execution and the board setting oversight. In AngioDynamics ownership, no single controlling owner appears to direct the firm, so voting power is spread across shareholders, institutions, and insiders.

Who owns AngioDynamics is best read as a shared-control setup, not a founder-led or privately controlled one. That matters because the AngioDynamics public company ownership structure gives outside holders real votes, while the board and CEO still control day-to-day decisions. For a wider look at the business backdrop, see the Competitors Landscape of AngioDynamics.

Who holds real influence

Real power sits with the board, the CEO, and the largest holders. That usually means AngioDynamics institutional ownership matters more than any single retail block.

• Board committees shape oversight and risk.
• Institutions influence votes and expectations.
• Insider ownership is usually modest.
• No clear controlling owner is disclosed.

AngioDynamics company profile fits a standard U.S. listed medtech model: is AngioDynamics publicly traded, yes, and is AngioDynamics privately owned, no. That means AngioDynamics stock ownership breakdown depends on filings, proxy votes, and fund positioning, not on one founder block. If you are asking who founded AngioDynamics or who is the largest shareholder of AngioDynamics, the practical answer for governance is still the same: influence is broad, and AngioDynamics major institutional holders can matter a lot at the ballot box.

AngioDynamics shareholder list typically includes institutions, executives, and other public market holders rather than a controller. In small-cap medtech names, that often leaves AngioDynamics executive ownership and AngioDynamics board of directors ownership meaningful but not dominant. So, AngioDynamics stockholders have formal voting power, yet the board and management still steer strategy, capital use, and risk choices.

• One-share, one-vote is the likely setup.
• No dual-class control is widely disclosed.
• Independent directors improve oversight.
• Institutions can pressure governance outcomes.
• Management drives daily operating decisions.

AngioDynamics Balanced Scorecard

• Clean, Modern, and Easy to Present
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

AngioDynamics ownership has stayed steady through 2025 and into 2026: it remains a publicly traded, SEC-reporting company with no controlling family, parent, or buyout sponsor. That setup supports transparency, but the market still judges AngioDynamics shareholders on execution, so credibility can shift fast if growth or margins weaken.

For anyone asking Who owns AngioDynamics, the key point is that ownership is spread across AngioDynamics investors rather than locked in by a founder or sponsor. That usually helps brand credibility because AngioDynamics stockholders can review filings, vote on directors, and track board accountability, but it also means the story can change with each earnings cycle. For a deeper view of the business mix around ownership and customers, see Target Market of AngioDynamics.

Public ownership supports trust

AngioDynamics public company ownership structure gives investors filing access and voting rights. That transparency is a major plus for brand credibility.

No control story to discount

There is no clear sign of a parent-company takeover, privatization, or founder-led control shift. So the ownership story has stayed stable.

Institutional holders matter most

AngioDynamics institutional ownership is the main ownership lens for market watchers. Large funds can influence sentiment fast when performance changes.

Execution drives credibility

AngioDynamics company profile is credible because it is public and governed, but small-cap medtech names face more scrutiny when growth slows. That makes quarterly results and insider ownership signals more important.

AngioDynamics VRIO Analysis

• Designed for Fast Business Analysis
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔